新型胆道与胰管可降解支架置入:单中心前瞻性先导研究(附视频)
主要终点为通过腹部X线评估的支架降解时间,次要终点为支架操作性及不良事件。结果显示支架降解可靠且与预期时间一致,技术成功率高,仅发生1例轻度ERCP后胰腺炎。
要点
- 新型螺旋形胆道/胰管可降解支架降解时间与预期一致,完全降解率100%。
- 仅1例轻度ERCP后胰腺炎,安全性初步良好,需随机多中心研究验证。
核心结论
- 新型胆道与胰管可降解支架的降解可靠且与预期时间一致,在多种适应证中技术成功。
研究设计与样本
- 共置入53枚可降解支架,其中胆道34枚(64.2%)、胰管19枚(35.8%)。
- 支架降解速度:慢速35枚(66%)、中速6枚(11.3%)、快速12枚(22.6%)。
主要发现
- 时间点1评估时,48枚支架(90.6%)出现部分降解,5枚(9.4%)提前迁移。
- 后续时间点2评估时,100%病例实现完全降解。
- 支架装载性在所有病例中均为优;推送性优48例(90.5%)、良4例(7.5%)、可1例(1.9%)。
- 透视可见性优11例(20.8%)、良39例(73.6%)、可3例(5.6%)。
- 仅发生1例轻度ERCP后胰腺炎不良事件。
临床怎么用
- 对于有胆道或胰管塑料支架置入指征的患者,可考虑使用新型可降解支架,其降解时间可按慢速(11周)、中速(20天)、快速(12天)选择。
- 操作中支架装载性、推送性和透视可见性总体良好,可作为传统塑料支架的潜在替代。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In recent years, the feasibility and safety of endoscopic placement of different biodegradable biliary stents have been investigated. New, helicoidally shaped, biliary and pancreatic biodegradable stents have been developed for endoscopic use. Stents are provided in different sizes and with 3 expected speeds of degradation: slow (11 weeks), medium (20 days), and fast (12 days). The aim of this study was to evaluate degradation time, technical outcomes, and safety of these stents. METHODS: This was a single-center, prospective, pilot study (August 2018 to January 2019) of consecutive patients with indication for biliary or pancreatic plastic stent positioning during ERCP. The primary outcome was the evaluation of degradation time of the stents, which was controlled by abdominal radiograph. Secondary outcomes were the evaluation of specific stent-related technical features (loadability, pushability, and fluoroscopic visibility) as compared with commonly used plastic stents and adverse events (AEs). RESULTS: Thirty-eight patients (11 women [28.9%]; median age, 68.05 ± 10.74 years) who received 53 biodegradable stents (34 [64.2%] biliary and 19 [35.8%] pancreatic stents) were enrolled in the study. Thirty-five (66%) slow-degrading stents, 6 (11.3%) medium-degrading stents, and 12 (22.6%) fast-degrading stents were used. At time 1, partial degradation of the stents was present in 48 cases (90.6%). Five stents (9.4%) prematurely migrated. At the subsequent time 2 evaluation, complete degradation occurred in 100% of cases. Stent loadability was defined as excellent in all cases. Pushability of the stent was scored as excellent in 48 cases (90.5%), good in 4 cases (7.5%), and fair in 1 case (1.9%). Fluoroscopic visualization was excellent in 11 cases (20.8%), good in 39 cases (73.6%), and fair in 3 (5.6%). Only 1 AE of mild post-ERCP pancreatitis occurred. CONCLUSIONS: The results of our study suggest that the biodegradation of the new biliary and pancreatic stents is reliable and in line with expected times and technically successful in a variety of indications. Further randomized multicenter studies are required to validate our preliminary findings. (Clinical trial registration number: NCT03767166.).
引用
- Anderloni A, Fugazza A, Maroni L, et al. New biliary and pancreatic biodegradable stent placement: a single-center, prospective, pilot study (with video). Gastrointest Endosc. 2020. PMID: 32145287. doi:10.1016/j.gie.2020.02.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。